| Abstrakt: |
Competing Interests: Dr Moslehi is supported by the National Institutes of Health (R01HL141466, R01HL155990, R01HL160688, R01HL156021) and has served as a consultant or served on advisory boards for Novartis, Bristol-Myers Squibb, Takeda, Daiichi Sankyo, AstraZeneca, Myovant, Mallinckrodt Pharmaceuticals, Silverback Therapeutics, Kurome Therapeutics, Cytokinetics, BeiGene, Kiniksa, Prelude Therapeutics, TransThera Sciences, and Voyager Therapeutics. Dr Moslehi holds patents related to the diagnosis and treatment of myocarditis. |
